Merit Medical Q2 2023 revenue $320.1M (+8.5% YoY); non-GAAP EPS $0.81 beat

MERIT MEDICAL SYSTEMS INC

2023-Q2 EPS reported $0.70 revenue$617,621,000

Q2 2023 revenue $320.1M, up 8.5% YoY; constant currency organic growth 9.1%.
GAAP EPS $0.35 vs $0.27; non-GAAP EPS $0.81 vs $0.73, both YoY increases.
GAAP operating margin 9.0% vs 7.9%; non-GAAP operating margin 19.9% vs 19.1%.
No guidance update; results reflect broad-based growth across product lines.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MERIT MEDICAL SYSTEMS INC reported Q2 2023 results: revenue $320.1 million, EPS $0.35.

Period: Q2 2023
Revenue: $320.1 million
EPS: $0.35
Result: reported results

Exact text from the filing

MERIT MEDICAL REPORTS RESULTS FOR SECOND QUARTER JUNE 30, 2023 ● Q2 2023 reported revenue of $320.1 million, up 8.5% year-over-year ● Q2 2023 constant currency revenue* up 9.4% year over year ● Q2 2023 constant currency revenue, organic* up 9.1% year-over-year ● Q2 2023 GAAP operating margin of 9.0%, compared to 7.9% in Q2 2022 ● Q2 2023 non-GAAP operating margin* of 19.9%, compared to 19.1% in Q2 2022 ● Q2 2023 GAAP EPS $0.35, compared to $0.27 in Q2 2022 ● Q2 2023 non-GAAP EPS* of $0.81, compared to $0.73 in Q2 2022

View on SEC.gov

Browse all earnings releases →

MERIT MEDICAL SYSTEMS INC filing history →

Source: SEC EDGAR

accession 0000856982-23-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.